A genetic family-based association study of OLIG2 in obsessive-compulsive disorder

Archives of General Psychiatry

Volumn 64, Issue 2, 2007, Pages 209-215

  Stewart, S Evelyn ^a   Platko, Jill ^a   Fagerness, Jesen ^a   Birns, Julie ^a   Jenike, Eric ^a   Smoller, Jordan W ^a   Perlis, Roy ^a   Leboyer, Marion ^b   Delorme, Richard ^c   Chabane, Nadia ^c   Rauch, Scott L ^a   Jenike, Michael A ^a   Pauls, David L ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b University of Paris   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GILLES DE LA TOURETTE SYNDROME; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2 GENE; OUTCOME ASSESSMENT; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHROMOSOME MAPPING; COMORBIDITY; FAMILY; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; NERVE TISSUE PROTEINS; OBSESSIVE-COMPULSIVE DISORDER; PEDIGREE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; TOURETTE SYNDROME;

EID: 33846889750     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.64.2.209     Document Type: Article

References (45)

1. Calvocoressi L, Libman D, Vegso SJ, McDougle CJ, Price LH. Global functioning of inpatients with obsessive-compulsive disorder, schizophrenia, and major depression. Psychiatr Serv. 1998;49:379-381.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition . Washington, DC: American Psychiatric Association; 1980.
3. Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45:1094-1099.
4. Weissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, Lee CK, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wickramaratne PJ, et al. The cross national epidemiology of obsessive compulsive disorder. J Clin Psychiatry. 1994;55:5-10.
5. Hanna GL, Veenstra-VanderWeele J, Cox NJ, et al. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet. 2002;114:541-552.
6. Zhang H, Leckman JF, Pauls DL, Boehnke M, Himle JA, Curtis GC, Leventhal BL, Cook EH Jr. Genomewide scan of hoarding sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet. 2002;70:896-904.
7. Pauls DL, Stewart SE. Genetics of obsessive-compulsive disorder. Trends Evid Based Neuropsychiatry. In press.
8. Urraca N, Camarena B, Gomez-Caudillo L, Esmer MC, Nicolini H. μ Opioid receptor gene as a candidate for the study of obsessive compulsive disorder with and without tics. Am J Med Genet B Neuropsychiatr Genet. 2004;127:94-96.
9. Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry. 1987;44:211-218.
10. Rauch SL, Shin LM, Dougherty DD, Alpert NM, Fischman AJ, Jenike MA. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study. Neuropsychopharmacology. 2002;27:782-791.
11. Nakatani E, Nakgawa A, Ohara Y, Goto S, Uozumi N, Iwakiri M, Yamamoto Y, Motomura K, Iikura Y, Yamagami T. Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Res. 2003;124:113-120.
12. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998;(35):26-37.
13. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23:563-586.
14. Rauch SL, Baxter LR. Neuroimaging of OCD and related disorders. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive-Compulsive Disorders: Practical Management. St Louis, Mo: Mosby-Year Book Inc; 1998:289-317.
15. Cannistraro PA, Wright CI, Wedig MM, Martis B, Shin LM, Wilhelm S, Rauch SL. Amygdala responses to human faces in obsessive-compulsive disorder. Biol Psychiatry. 2004;56:916-920.
16. Jenike MA, Breiter HC, Baer L, Kennedy DN, Savage CR, Olivares MJ, O'Sullivan RL, Shera DM, Rauch SL, Keuthen N, Rosen BR, Caviness VS, Filipek PA. Cerebral structural abnormalities in obsessive-compulsive disorder: a quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry. 1996;53:625-632.
17. Breiter HC, Filipek PA, Kennedy DN, Baer L, Pitcher DA, Olivares MJ, Renshaw PF, Caviness VS Jr. Retrocallosal white matter abnormalities in patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1994;51:663-664.
18. Szeszko PR, Ardekani BA, Ashtari M, Malhotra AK, Robinson DG, Bilder RM, Lim KO. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study. Arch Gen Psychiatry. 2005;62:782-790.
19. Takebayashi H, Nabeshima Y, Yoshida S, Chisaka O, Ikenaka K, Nabeshima Y. The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr Biol. 2002;12:1157-1163.
20. Human Gene Atlas: 1H, gcRMA 213825. Genomics Institute of the Novartis Research Foundation. http://symatlas.gnf.org/SymAtlas/. Accessed December 1, 2005.
21. Fancy SP, Zhao C, Franklin RJ. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci. 2004;27:247-254.
22. Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Wang Y, Pinto A, Fyer AJ, Piacentini J, Pauls B, Cullen B, Page J, Rasmussen SA, Bienvenu OJ, Hoehn-Saric R, Valle D, Liang K-Y, Riddle MA, Nestadt G. Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry. 2006;11:763-770.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
24. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press; 1996.
25. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. Schedule for Affective Disorders and Schizophrenia for School Age Children-Present and Lifetime Version (KSADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980-988.
26. Tourette Syndrome Association International Consortium for Genetics (TSAICG). A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. Am J Hum Genet. 1999;65:1428-1436.
27. Goodman WK, Price L, Rasmussen S, Mazure C, Fleischman R, Hill C, Heninger G, Charney D. The Yale-Brown Obsessive Compulsive Scale, I: development use and reliability. Arch Gen Psychiatry. 1989;46:1006-1011.
28. Leckman JF, Riddle M, Hardin M, Ort S, Swartz K, Stevenson J, Cohen D. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28:566-573.
29. Leckman JF, Scholomskas D, Thompson W, Belanger A, Weissman M. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry. 1982;39:879-883.
30. Gentra. Protocol for the purification of DNA from whole blood. http://gentra.com. Accessed July 13, 2005.
31. Tagger: selection and evaluation of tag SNPs. Broad Institute Web site. http://www.broad.mit.edu/mpg/tagger/. Accessed July 13, 2005.
32. Multiplexing the homogeneous MassEXTEND Assay. http://www.sequenom.com/ Assets/pdfs/appnotes/Multiplexing_hME_App_Note.pdf. Accessed July 13, 2005.
33. Riva A, Kohane IS. SNPper: retrieval and analysis of human SNPs. Bioinformatics. 2002;18:1681-1685.
34. Harvard School of Public Health. FBAT Web page for SNPper. http://www.biostat.harvard.edu/~fbat/default.html. Accessed July 13, 2005.
35. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265.
36. Xu X, Tian L, Wei LJ. Combining dependent tests for linkage or association across multiple phenotypic traits. Biostatistics. 2003;4:223-229.
37. Harvard School of Public Health. FBAT Web Page for FBAT 1.5.5. http://www.biostat.harvard.edu/~fbat/default.html. Accessed July 13, 2005.
38. LocusView 2.0 documentation. http://www.broad.mit.edu/mpg/locusview/ LocusView2.0_documentation.doc. Accessed September 13, 2005.
39. Miguel EC, Leckman JF, Rauch S, do Rosario-Campos MC, Hounie AG, Mercadante MT, Chacon P, Pauls DL. Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry. 2005;10:258-275.
40. McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. J Clin Psychopharmacol. 1993;13:354-358.
41. Leckman JF, Grice DE, Barr LC, de Vries AL, Martin C, Cohen DJ, McDougle CJ, Goodman WK, Rasmussen SA. Tic-related vs. non-tic-related obsessive-compulsive disorder. Anxiety. 1994;1:208-215.
42. Cath DC, Spinhoven P, van Woerkom TC, van de Wetering BJ, Hoogduin CA, Landman AD, Roos RA, Rooijmans HG. Gilles de la Tourette syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without tics: which symptoms discriminate? J Nerv Ment Dis. 2001;189:219-228.
43. Cath DC, Spinhoven P, van de Wetering BJ, Hoogduin CA, Landman AD, van Woerkom TC, Roos RA, Rooijmans HG. The relationship between types and severity of repetitive behaviors in Gilles de la Tourette's disorder and obsessive-compulsive disorder. J Clin Psychiatry. 2000;61:505-513.
44. Petter T, Richter MA, Sandor P. Clinical features distinguishing patients with Tourette's syndrome and obsessive-compulsive disorder from patients with obsessive-compulsive disorder without tics. J Clin Psychiatry. 1998;59:456-459.
45. Purcell S, Sham P. Genetic power calculator. http://pngu.mgh.harvard.edu/ ~purcell/gpc/. Accessed December 7, 2005.